NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against James Hardie Industries plc ("James Hardie" or the "Company") (NYSE:JHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by […]
NEW YORK, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Stride, Inc. ("Stride" or the "Company") (NYSE:LRN).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ:SNPS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE:ARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by
For the millions of programmers, creative professionals, and remote workers battling the inertia of sedentary work, a breakthrough moment has arrived. LiberNovo, the company pioneering the next generation of workspace solutions, today announced the global, full-inventory launch of the LiberNovo Omni – the world's first dynamic ergonomic office chair designed to adapt to your body's
NEW YORK CITY, NY / ACCESS Newswire / December 6, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Perrigo Company plc ("Perrigo" or the "Company") (NYSE:PRGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
(NASDAQ:PRLD), First disclosure of PRT12396, a JAK2V617F-selective JH2 inhibitor demonstrates disease modifying potential in myeloproliferative neoplasms PRT12396 has completed GLP toxicology studies and is on track for IND filing in the first quarter 2026 First disclosure of a mutant calreticulin (mCALR) targeted degrader antibody conjugate (DAC) with a novel CDK9 degrader payload JAK2V617F and mCALR
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs GlobeNewswire December 06, 2025 First disclosure of PRT12396, a JAK2V617F-selective JH2 inhibitor demonstrates disease modifying potential in myeloproliferative neoplasms PRT12396 has completed GLP toxicology studies and is on track for IND filing in the first quarter 2026 First disclosure
The law firm of Kessler Topaz Meltzer & Check, LLPinforms investors that a securities class action lawsuit has been filed against Firefly Aerospace Inc. (“Firefly”) (NASDAQ: FLY) on behalf of those who purchased or otherwise acquired Firefly: (1) common stock pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued
Robbins Geller Rudman & Dowd LLP announces that purchasers of Sprouts Farmers Market, Inc. (NASDAQ: SFM) securities between June 4, 2025 and October 29, 2025, both dates inclusive (the “Class Period”), including sellers of put options, have until January 26, 2026 to seek appointment as lead plaintiff of the Sprouts class action lawsuit. CaptionedSingh Family